Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jaungo in Atopic Dermatitis
NCT02900131Phase 2Completed
- Sponsor
- Kyung Hee University Hospital
- Start
- Sep 2016
- Primary completion
- Mar 2017
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Jaungo in atopic dermatitis (AD) (3 arms), sponsored by Kyung Hee University Hospital. Primary endpoint: Eczema Area and Severity Index at 3 weeks. Started Sep 2016; status: completed.
02
Drugs
Jaungo
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02900131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02900131.